HFE
Chr 6ARhomeostatic iron regulator
Also known as: HFE1, HH, HLA-H, MVCD7, TFQTL2
The protein encoded by this gene is a membrane protein that is similar to MHC class I-type proteins and associates with beta2-microglobulin (beta2M). It is thought that this protein functions to regulate iron absorption by regulating the interaction of the transferrin receptor with transferrin. The iron storage disorder, hereditary haemochromatosis, is a recessive genetic disorder that results from defects in this gene. [provided by RefSeq, May 2022]
Primary Disease Associations & Inheritance
Definitive — sufficient evidence for diagnostic panels
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Highly tolerant — LoF variants common in population
Mild missense constraint
ClinVar Variant Classifications
349 submitted variants in ClinVar
Classification Summary
Curated Variants Distribution
Classified variants from ClinVar · 5 ACMG categories
| Classification | LoF | Missense + Inframe | Non-coding | Synonymous | Total |
|---|---|---|---|---|---|
Pathogenic | 10 | 1 | 21 | 0 | 32 |
Likely Pathogenic | 13 | 3 | 4 | 0 | 20 |
VUS | 5 | 88 | 38 | 1 | 132 |
Likely Benign | 0 | 1 | 43 | 96 | 140 |
Benign | 0 | 0 | 9 | 1 | 10 |
Conflicting | — | 15 | |||
| Total | 28 | 93 | 115 | 98 | 349 |
LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly
View in ClinVar →Protein Context — Lollipop Plot
HFE · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
Gene2Phenotype Curations
HFE-related haemochromatosis
definitiveGene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org
OMIM — Genotype-Phenotype Relationships
1 OMIM entry
External Resources
Links to major genomics databases and tools
Variant Interpretation
Population Databases
Gene Resources
Expert Curation
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
ACTIVE NOT RECRUITINGEfficacy of Montelukast on STEMl Patients
RECRUITINGT1 Mapping in Fabry Disease
RECRUITINGNeoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)
RECRUITINGA Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
RECRUITINGA Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
ACTIVE NOT RECRUITINGQL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC
RECRUITINGPhase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
RECRUITINGClinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
RECRUITINGCognitive Decline and Underlying Mechanisms in Asymptomatic Intracranial Artery Stenosis Patients
RECRUITINGA Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
RECRUITINGSafety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS)
ACTIVE NOT RECRUITINGExternal Resources
Links to major genomics databases and tools